D Reviron

3.6k citations
60 papers · 2.7k indexed · 1 hit paper · h-index 21

D Reviron

58 papers receiving 2.7k citations

Hit Papers

Human NK Cell Education by Inhibitory Receptors for MHC C...9162006202620122019250500750

Peers

D Reviron
Comparison fields: 5 of 102
  • Immunology 1.8k
  • Hematology 721
  • Rheumatology 495
  • Oncology 551
  • Genetics 194
Replace David Senitzer with:
David Senitzer United States
Henrik Zetterquist Sweden
Hans Peter Germany
G. M. T. Schreuder Netherlands
Bimba F. Hoyer Germany
David A. Fulcher Australia
Julie Déchanet France
W Hinterberger Austria
Armead H. Johnson United States
Massimo Fiorilli Italy
D Reviron relative to David Senitzer United States David Senitzer's profile →
Citations per field
00.5×1.5×1.9×
David Senitzer · 1×
Citations per year

Countries citing papers authored by D Reviron

Since Specialization
Citations

This map shows the geographic impact of D Reviron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Reviron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Reviron more than expected).

Fields of papers citing papers by D Reviron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Reviron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Reviron. The network helps show where D Reviron may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D Reviron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D Reviron Line = papers co-authored together D Reviron links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201354
2 200719
3 200710
4 200624
5 20067
6 200566
7 2003169
8 200319
9 200339
10 200157
11 200037
12 20007
13 200016
14 199987
15 19995
16 19976
17 19953
18 19932
19 19910
20 19911

About D Reviron

D Reviron is a scholar working on Transplantation, Hematology, Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 60 papers that have together received 2.7k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (15 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Systemic Lupus Erythematosus Research (10 papers), Immune Cell Function and Interaction (10 papers), Blood groups and transfusion (10 papers), Rheumatoid Arthritis Research and Therapies (10 papers), Platelet Disorders and Treatments (8 papers) and Diabetes and associated disorders (4 papers). The work is most often cited by research in Immunology (1.8k citations), Hematology (721 citations), Rheumatology (495 citations), Oncology (551 citations) and Genetics (194 citations). D Reviron has collaborated with scholars based in France, Switzerland and Italy. Frequent co-authors include Jean Roudier, Coralie Frassati, Éric Vivier, Nathalie Balandraud, Charles A. Stewart, Sophie Guia, Pascale André, François Romagné, Nicolas Anfossi and Sophie Ugolini. Their work appears in journals such as Transfusion, European Journal of Epidemiology, Human Immunology, Immunogenetics and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026